Description: Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.
Home Page: www.acertx.com
ACER Technical Analysis
One Gateway Center
Newton,
MA
02458
United States
Phone:
844 902 6100
Officers
| Name | Title |
|---|---|
| Mr. Christopher Schelling | Founder, Pres, CEO & Director |
| Mr. Harry S. Palmin | Chief Financial Officer |
| Mr. Jefferson E. Davis | Chief Bus. Officer |
| Ms. Tanya Hayden | Chief Operating Officer |
| Mr. John Michael Klopp | Chief Technical Officer |
| Mr. Donald R. Joseph J.D. | Chief Legal Officer & Sec. |
| Mr. Bernie Paul | Chief People Officer |
| Mr. Matthew T. Seibt | Chief Commercial Officer |
| Dr. Adrian Quartel FFPM, M.D. | Chief Medical Officer |
| Mr. Jason Kneeland CPA | VP of Fin. & Controller |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 17.2561 |
| Price-to-Sales TTM: | 174.5231 |
| IPO Date: | 2017-09-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 41 |